$8.355
-0.104 (-1.24%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
HBIO Prediction & Forecast by Similar Chart Analysis
Alphio's HBIO stock price prediction model matches the current Harvard Bioscience Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.33 (-0.25%). The 1-week path is $8.23 (-1.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Harvard Bioscience Inc Stock?
Harvard Bioscience Inc is currently not a strong buy due to recent performance and financial metrics. The current price is $8.35, which is above the analyst's target of $7.50, indicating limited upside potential. The RSI is at 39.47, suggesting the stock is nearing oversold territory, but the negative trend in recent changes (-6.12% over the last 5 days) raises concerns. Additionally, the company reported a widening net loss of $2.9 million in Q2 2026, and the forward P/E ratio is at 15.06, which is relatively high given the current financial instability. The main risk is the company's significant debt-to-equity ratio of 494.50%, indicating potential financial distress.
HBIO stock price ended at $8.35 on Friday, after losing -1.24%
Harvard Bioscience Inc (HBIO) last closed at $8.3549995, losing -1.24%. These facts feed the 1-day and 1-week HBIO price prediction above.
Analyst Consensus
Harvard Bioscience Inc (HBIO): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Harvard Bioscience Inc (HBIO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches HBIO, ranked by similarity.
Seasonality analysis for HBIO
Historically the probability of a positive November return for HBIO is 11.36%. September offers the highest probability of a positive month at 33.87%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for HBIO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.21 | $0.22 | $0.29 | -97.34% |
| Dec 2026 | $0.18 | $0.25 | $0.27 | -97.03% |
In 2026, Harvard Bioscience Inc (HBIO) is projected to range from $0.18 to $0.29.
Harvard Bioscience Inc 2026 monthly forecast
In Nov 2026, Harvard Bioscience Inc is projected to average $0.22, with a low of $0.21 and high of $0.29.
In Dec 2026, Harvard Bioscience Inc is projected to average $0.25, with a low of $0.18 and high of $0.27.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.